Outcome of Endovascular Treatment in Symptomatic Intracranial Vascular Stenosis
Open Access
- 1 January 2005
- journal article
- Published by The Korean Society of Radiology in Korean Journal of Radiology
- Vol. 6 (1), 1-7
- https://doi.org/10.3348/kjr.2005.6.1.1
Abstract
The outcome evaluation for the revascularization of intracranial vascular stenoses has not been fully described due to the highly technical nature of the procedure. We report here on the early and late clinical outcomes of angioplasty and/or stenting of symptomatic severe intracranial vascular stenoses at a single institute. Since 1995, we have treated 35 patients with symptomatic intracranial vascular stenosis (more than 70% stenosis, mean stenosis: 78.6% ± 6.2%). Angioplasty (n = 19) was performed for the horizontal segment of the middle cerebral artery (M1) (n = 16) and the basilar artery (BA) (n = 1), the intradural vertebral artery (VA) (n = 1), and the cavernous internal carotid artery (ICA) (n = 1). Stenting (n = 16) was performed for the cavernous or petrous ICAs (n = 9), the intradural VA (n = 3), BA (n = 2), and M1 (n = 2) artery. We assessed the angiographic success (defined as residual stenosis < 50%) rate, the periprocedural complications during the 30-day periprocedural period, the symptomatic recurrence and restenosis during a mean 22-month follow-up (FU) period. The Kaplan-Meier estimate of the cumulative event-free rate of the major cerebrovascular events, i.e. death, stroke or restenosis, was also done. Angiographic success was achieved in 97% of our patients (34/35). There were four procedure-related complications (11%) including a death and a minor stroke. During the mean 22-month FU, the asymptomatic restenosis rate was 9% and the symptomatic restenosis rate was 6% in the target lesion and 9% in all the vascular territories. The Kaplan-Meier estimate was 70.6% (95% confidence interval = 46.5-94.7) after 33 months of FU. In addition to a high angiographic success rate and an acceptable periprocedural complication rate, intracranial angioplasty and/or stenting revealed a relatively low symptomatic recurrence rate. Hemorrhage is a rare, but the physician must aware that potentially fatal periprocedural complications can occur.Keywords
This publication has 34 references indexed in Scilit:
- Comparison of periprocedure complications resulting from direct stent placement compared with those due to conventional and staged stent placement in the basilar arteryJournal of Neurosurgery, 2003
- Design, Progress and Challenges of a Double-Blind Trial of Warfarin versus Aspirin for Symptomatic Intracranial Arterial StenosisNeuroepidemiology, 2003
- Staged stent-assisted angioplasty for symptomatic intracranial vertebrobasilar artery stenosisJournal of Neurosurgery, 2002
- Transluminal Stent-assisted Angioplasty of the Intracranial Vertebrobasilar System for Medically Refractory, Posterior Circulation Ischemia: Early ResultsNeurosurgery, 2001
- Prognosis of Patients With Symptomatic Vertebral or Basilar Artery StenosisStroke, 1998
- Reliability of the National Institutes of Health Stroke ScaleStroke, 1997
- Race and Sex Differences in the Distribution of Cerebral AtherosclerosisStroke, 1996
- Race-Ethnicity and Determinants of Intracranial Atherosclerotic Cerebral InfarctionStroke, 1995
- Superficial temporal and occipital artery bypass pedicles to superior, anterior inferior, and posterior inferior cerebellar arteries for vertebrobasilar insufficiencyJournal of Neurosurgery, 1990
- Failure of Extracranial–Intracranial Arterial Bypass to Reduce the Risk of Ischemic StrokeNew England Journal of Medicine, 1985